Yijing Capital
Shanghai Yijing Investment Co., Ltd., established in 2015, is a venture capital firm headquartered in Shanghai, China, with regional offices in Beijing, Hong Kong, Singapore, and Sydney. The firm specializes in seed stage investments and focuses on sectors with high growth potential, particularly medical and healthcare, smart manufacturing, technology, media, and telecommunications, as well as consumer products and services. Yijing Capital operates multiple investment platforms and engages in equity investment using both self-owned and externally sourced funds. The firm has completed numerous investment projects both domestically and internationally, with a significant emphasis on healthcare and smart manufacturing. Many of the companies in which Yijing has invested have experienced robust growth, with some successfully going public, while others have generated strong returns upon exit. Yijing Capital is recognized for its professional investment approach and the extensive operational and managerial expertise of its core team.
NowYonMedical specializes in the production of medical device products. It also offers technical consulting, health management, and technology research in the field of life sciences.
CytoNiche focuses on the development of 3D micro-organization engineering technology. The core technology is derived from the transformation of Tsinghua University's achievements. Based on its original research technology, Huasheng Bio has launched a series of related products and services, including customized, large-scale, automated and intelligent stem cell culture. Amplification process; 3D stem cell micro-tissue regeneration treatment of new drugs and 3D cell high-throughput drug screening products.
InnoStar Semiconductor
Series A in 2022
InnoStar Semiconductor is a semiconductor storage technology service company.
Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. The company specializes in the development of small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Through its research and development efforts, Xgene Pharmaceutical seeks to address significant medical needs in these areas.
Developer of skin care products. The company focuses on promoting the industrialization of hyaluronic acid applications, and currently has a variety of products such as body care, hand and foot care, facial care and acne repair, providing clients with different kinds of skin care products.
ChosenMed
Series C in 2021
ChosenMed is a Healthcare company based in Beijing.
Nanjing Immunophage Biotech Co. Ltd., established in 2016 and based in China, focuses on developing innovative pharmaceutical therapies. The company operates a research and development center in the Pujiang High-Tech Park, Shanghai, where it specializes in creating first-in-class immune-regulating medicines. Immunophage is dedicated to addressing critical health challenges by developing drugs aimed at treating cancer, autoimmune diseases, and neurodegenerative disorders. Its therapeutic approach targets tumor growth inhibition and the reduction of Myeloid-derived suppressor cells, offering healthcare professionals more effective treatment options for patients.
Artivila Therapeutics is a pharmaceutical company established in 2018 and based in Shenzhen, China. The company specializes in biotechnology and is dedicated to improving patient outcomes through innovative drug discovery. Utilizing an AI-powered platform, Artivila focuses on developing new therapeutic solutions for neurodegenerative diseases, cancers, and autoimmune diseases. Its integrated approach aims to consistently and efficiently deliver first-in-class drug candidates, positioning Artivila at the forefront of pharmaceutical research and development.
Biren Technology, based in Shanghai, China, specializes in the design and manufacture of intelligent chips and processors tailored for various computing architectures, including GPU and DSA. The company operates in the high-tech sector, focusing on both hardware and software solutions. Its hardware division develops a range of computing solutions that blend versatility with specificity, while its software department is led by experienced industry professionals. The company also conducts frontier research on new intelligent computing systems, emphasizing innovative architectures and advanced compilation technologies. Biren Technology aims to provide integrated solutions for applications such as cloud computing, artificial intelligence training, graphics rendering, and high-performance general-purpose computing, enabling clients to utilize domestic chip solutions and achieve significant technological advancements.
Developer of small molecule drugs designed to tackle tumors. The company develops biomedical platforms to research innovative drugs for autoimmune and tumor diseases, enabling patients to get better treatments.
Beijing Zhiketong Technology Co., Ltd. is a digital marketing agency established in 2014 that specializes in providing marketing services for the hospitality, leisure, and entertainment sectors. The company operates primarily through WeChat, offering a range of solutions that include direct-sale marketing strategies, digital marketing consultation, advertising, and comprehensive data analysis. Zhiketong Technology aims to enhance management efficiency and service quality for its partners while improving brand visibility. Additionally, the company develops a software-as-a-service (SaaS) platform that equips clients, such as hotels and tourism attractions, with tools for customer management, online marketing, and product design, thereby enabling them to attract more customers and increase revenue. Headquartered in Beijing, Zhiketong Technology plays a significant role in optimizing the operational capabilities of its clients in the competitive digital landscape.
Developer and researcher of advanced directional protein renaturation technology. The company uses advanced technologies such as high-throughput protein re-screening and purification technology platform, fixed point protein coupling design platform, high-throughput protein drug formulation development platform in their research, enabling the development of more effective protein-based drugs.
eTheRNA immunotherapies NV specializes in the development of mRNA-based immunotherapies aimed at enhancing the human immune system's response to cancer and infectious diseases. The company's innovative TriMix technology specifically targets dendritic cells, which play a crucial role in initiating immune responses. By harnessing this technology, eTheRNA seeks to provide more effective and safer treatment options for patients with conditions such as melanoma and triple-negative breast cancer. Founded in 2013 and headquartered in Niel, Belgium, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its research and development efforts. The company is dedicated to advancing the field of immunotherapy to improve patient outcomes.
Yidebang is a Beijing-based healthcare software developer, which provides management solution, drug supply, hierarchical diagnosis and treatment and other supporting medical services for basic-level clinics in China.
Iyiou.com is an industrial tech media and investment research company that focuses on technological and industrial innovation in China
Shanutec is a developer of smart household equipment and applications, focusing on enhancing domestic living through innovative technology. The company specializes in creating smart home systems and appliances, including electrical wiring solutions for both residential and commercial spaces. Shanutec offers a range of products such as power tracks with removable electric sockets, energy management systems, and environmental and safety systems. These offerings enable homeowners to easily install and manage smart appliances, ultimately contributing to a more comfortable and efficient living environment.
Iyiou.com is an industrial tech media and investment research company that focuses on technological and industrial innovation in China
Veritas Genetics International Ltd. offers genetic testing services aimed at empowering individuals to improve their health and longevity. Based in Danvers, Massachusetts, the company collaborates with scientists, physicians, and patient advocates to develop comprehensive genetic testing solutions. Its advanced genetic technology surpasses traditional next-generation sequencing by detecting a broader range of gene variations. Veritas Genetics also provides a screening test focused on hereditary breast and ovarian cancer risk, facilitating informed decision-making for clinical researchers and healthcare providers. The company operates across North America, Asia, and Europe, striving to enhance the understanding of genetic health.
Iyiou.com is an industrial tech media and investment research company that focuses on technological and industrial innovation in China
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.